|drug2674||Quantitative analysis of SARS-CoV-2 antibodies Wiki||1.00|
|drug2873||SARS-CoV-2 diagnostic rapid test Wiki||0.71|
|D045169||Severe Acute Respiratory Syndrome NIH||0.04|
|D018352||Coronavirus Infections NIH||0.04|
There is one clinical trial.
This is a randomised, multi-center, open label, adaptive, exploratory trial to assess the efficacy of two different drug regimens in terms of preventing symptomatic COVID-19 disease in healthcare workers at high risk of exposure to SARS-CoV-2. The trial will compare two different experimental medication arms to the control arm comprising the use of standard personal protective equipment (PPE) with no additional pharmacological intervention.
Description: Number of SARS-CoV-2 infection (COVID-19) confirmed by PCR and/or serology.Measure: Number of SARS-CoV-2 infections Time: 6 months
Description: Duration of symptoms for each symptomatic infectionMeasure: Duration of symptoms Time: 6 months
Description: Maximum score on WHO Ordinal Scale for Clinical Improvement for each symptomatic infection. Score of 0 being uninfected and a score of 8 being dead.Measure: Maximum score on WHO Ordinal Scale Time: 6 months
Description: Time to onset of SARS-CoV-2 infection (COVID-19) confirmed by PCR and/or serologyMeasure: Time to onset of SARS-CoV-2 infection Time: 6 months
Description: Number of symptomatic SARS-CoV-2 infection (COVID-19) confirmed by PCR and/or serologyMeasure: Number of symptomatic SARS-CoV-2 infections Time: 6 months
Description: Number of asymptomatic • Asymptomatic SARS-CoV-2 infection suggested by serological outcomeMeasure: Number of asymptomatic SARS-CoV-2 infections Time: 6 months
Description: Peak score on modified Flu-PRO during each symptomatic infection. 37-item questionairre assessing the severity of flu like symptoms one a scale of 0 - not at all to 5 - very much.Measure: Peak score on modified Flu PRO Time: 6 months
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports